(DG) Dollar General - Overview
Stock: Consumables, Seasonal, Home, Apparel
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.21% |
| Yield on Cost 5y | 1.29% |
| Yield CAGR 5y | 9.86% |
| Payout Consistency | 95.0% |
| Payout Ratio | 35.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.9% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.96 |
| Alpha | 102.46 |
| Character TTM | |
|---|---|
| Beta | -0.064 |
| Beta Downside | -0.297 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.52% |
| CAGR/Max DD | -0.18 |
Description: DG Dollar General December 19, 2025
Dollar General (DG) operates a network of over 19,400 discount-store locations across the southern, southwestern, mid-Midwest and eastern United States, targeting price-sensitive shoppers with a broad assortment of consumables, perishables, seasonal items and basic apparel.
The retailer’s product mix emphasizes high-turn, low-margin categories such as paper goods, packaged foods, dairy, and over-the-counter health products, while also offering ancillary lines like pet supplies, small electronics, and tobacco to capture incremental basket size.
Founded in 1939 as J.L. Turner & Son and renamed Dollar General in 1968, the company is headquartered in Goodlettsville, Tennessee, and is classified under the GICS sub-industry “Consumer Staples Merchandise Retail.”
Key performance indicators as of FY 2024 include a 4.2 % same-store sales growth rate, an operating margin of roughly 10.5 %, and free cash flow generation of $1.2 billion, reflecting the chain’s ability to expand profitably in low-income and rural markets.
Macro-level drivers that materially affect DG’s outlook are persistent inflation (which boosts demand for low-price alternatives), a relatively inelastic demand for staple goods, and demographic trends that favor convenience-oriented retail formats in underserved zip codes.
For a deeper, data-driven look at DG’s valuation and risk profile, the ValueRay analysis provides a concise next step.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.28b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.14 > 1.0 |
| NWC/Revenue: 2.91% < 20% (prev 2.65%; Δ 0.26% < -1%) |
| CFO/TA 0.11 > 3% & CFO 3.62b > Net Income 1.28b |
| Net Debt (15.27b) to EBITDA (2.92b): 5.23 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.0m) vs 12m ago 0.44% < -2% |
| Gross Margin: 30.41% > 18% (prev 0.28%; Δ 3012 % > 0.5%) |
| Asset Turnover: 133.3% > 50% (prev 127.7%; Δ 5.66% > 0%) |
| Interest Coverage Ratio: 7.75 > 6 (EBITDA TTM 2.92b / Interest Expense TTM 244.2m) |
Altman Z'' 1.27
| A: 0.04 (Total Current Assets 8.38b - Total Current Liabilities 7.15b) / Total Assets 31.72b |
| B: 0.13 (Retained Earnings 4.10b / Total Assets 31.72b) |
| C: 0.06 (EBIT TTM 1.89b / Avg Total Assets 31.59b) |
| D: 0.18 (Book Value of Equity 4.30b / Total Liabilities 23.53b) |
| Altman-Z'' Score: 1.27 = BB |
Beneish M -3.51
| DSRI: 0.54 (Receivables 65.4m/115.7m, Revenue 42.12b/40.17b) |
| GMI: 0.94 (GM 30.41% / 28.48%) |
| AQI: 0.99 (AQ_t 0.18 / AQ_t-1 0.18) |
| SGI: 1.05 (Revenue 42.12b / 40.17b) |
| TATA: -0.07 (NI 1.28b - CFO 3.62b) / TA 31.72b) |
| Beneish M-Score: -3.51 (Cap -4..+1) = AAA |
What is the price of DG shares?
Over the past week, the price has changed by +2.24%, over one month by +1.35%, over three months by +53.51% and over the past year by +106.42%.
Is DG a buy, sell or hold?
- StrongBuy: 8
- Buy: 4
- Hold: 19
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 139.3 | -5% |
| Analysts Target Price | 139.3 | -5% |
| ValueRay Target Price | 166.4 | 13.5% |
DG Fundamental Data Overview February 04, 2026
P/E Forward = 20.202
P/S = 0.75
P/B = 3.8567
P/EG = 1.6835
Revenue TTM = 42.12b USD
EBIT TTM = 1.89b USD
EBITDA TTM = 2.92b USD
Long Term Debt = 5.12b USD (from longTermDebt, last quarter)
Short Term Debt = 1.54b USD (from shortTermDebt, last quarter)
Debt = 16.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.27b USD (from netDebt column, last quarter)
Enterprise Value = 46.86b USD (31.59b + Debt 16.51b - CCE 1.24b)
Interest Coverage Ratio = 7.75 (Ebit TTM 1.89b / Interest Expense TTM 244.2m)
EV/FCF = 20.03x (Enterprise Value 46.86b / FCF TTM 2.34b)
FCF Yield = 4.99% (FCF TTM 2.34b / Enterprise Value 46.86b)
FCF Margin = 5.55% (FCF TTM 2.34b / Revenue TTM 42.12b)
Net Margin = 3.03% (Net Income TTM 1.28b / Revenue TTM 42.12b)
Gross Margin = 30.41% ((Revenue TTM 42.12b - Cost of Revenue TTM 29.31b) / Revenue TTM)
Gross Margin QoQ = 29.90% (prev 31.34%)
Tobins Q-Ratio = 1.48 (Enterprise Value 46.86b / Total Assets 31.72b)
Interest Expense / Debt = 0.34% (Interest Expense 55.9m / Debt 16.51b)
Taxrate = 23.59% (87.3m / 369.9m)
NOPAT = 1.45b (EBIT 1.89b * (1 - 23.59%))
Current Ratio = 1.17 (Total Current Assets 8.38b / Total Current Liabilities 7.15b)
Debt / Equity = 2.02 (Debt 16.51b / totalStockholderEquity, last quarter 8.19b)
Debt / EBITDA = 5.23 (Net Debt 15.27b / EBITDA 2.92b)
Debt / FCF = 6.53 (Net Debt 15.27b / FCF TTM 2.34b)
Total Stockholder Equity = 7.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 1.28b / Total Assets 31.72b)
RoE = 16.31% (Net Income TTM 1.28b / Total Stockholder Equity 7.83b)
RoCE = 14.61% (EBIT 1.89b / Capital Employed (Equity 7.83b + L.T.Debt 5.12b))
RoIC = 10.67% (NOPAT 1.45b / Invested Capital 13.54b)
WACC = 3.82% (E(31.59b)/V(48.10b) * Re(5.68%) + D(16.51b)/V(48.10b) * Rd(0.34%) * (1-Tc(0.24)))
Discount Rate = 5.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.26%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈2.06b ; Y1≈2.54b ; Y5≈4.33b
Fair Price DCF = 504.0 (EV 126.20b - Net Debt 15.27b = Equity 110.94b / Shares 220.1m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -72.21 | EPS CAGR: -50.85% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.10 | Revenue CAGR: 5.70% | SUE: 0.54 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.95 | Chg30d=+0.008 | Revisions Net=+2 | Analysts=14
EPS next Year (2027-01-31): EPS=7.13 | Chg30d=+0.060 | Revisions Net=+5 | Growth EPS=+9.6% | Growth Revenue=+4.2%